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Virus replication
RNA synthesislitis virus (VEEV) is one of the most pathogenic members of the Alphavirus genus
in the Togaviridae family. Viruses in the VEEV serocomplex continuously circulate in the Central and South
America. The only currently available attenuated strain VEEV TC-83 is being used only for vaccination of at-
risk laboratory workers and military personnel. Its attenuated phenotype was shown to rely only on two
point mutations, one of which, G3A, was found in the 5′ untranslated region (5′UTR) of the viral genome. Our
data demonstrate that the G3A mutation strongly affects the secondary structure of VEEV 5′UTR, but has only
a minor effect on translation. The indicated mutation increases replication of the viral genome,
downregulates transcription of the subgenomic RNA, and, thus, affects the ratio of genomic and subgenomic
RNA synthesis. These ﬁndings and the previously reported G3A-induced, higher sensitivity of VEEV TC-83 to
IFN-α/β suggest a plausible explanation for its attenuated phenotype.
© 2009 Elsevier Inc. All rights reserved.IntroductionVenezuelan equine encephalitis virus (VEEV) is one of the most
pathogenic members of the Alphavirus genus in the Togaviridae family.
In nature, the serologically relatedviruseswithin theVEEVserocomplex
persistently replicate inmosquito vectors, which infect vertebrate hosts
during blood meals (Weaver and Barrett, 2004). In mammals, VEEV
infection is characterized by high-titer viremia, rash and fever, followed
by severe encephalitis that can result in death or neurological disorders
(Dal Canto and Rabinowitz, 1981; Grifﬁn, 2001; Johnston and Peters,
1996; Leon, 1975). Natural isolates of VEEV demonstrate some
differences in the antigenic structure (Weaver and Frolov, 2005) and
the severity of caused disease. In humans, the members of IAB and IC
subtypes are capable of causing diffuse congestion and edema with
hemorrhage in the brain, gastrointestinal (GI) tract, and lungs. Severe
necrosis and vasculitis occur in lymph nodes, spleen, and the GI tract,
accompanied by hepatocellular degeneration and interstitial pneu-
monia (de la Monte et al., 1985; Ehrenkranz and Ventura, 1974;
Johnson et al., 1968). Viruses in the VEEV serocomplex continuouslyand Immunology, BBRB 373/
, Birmingham, AL 35294-2170,
ll rights reserved.circulate in Central and South America, sometimes spreading into
Texas (Weaver et al., 2004). They have induced epidemics in equids,
and one of the recent outbreaks in Venezuela and Columbia also
involved ∼75,000 human cases and caused more than 20 deaths
(Rivas et al., 1997; Weaver et al., 1996).
In spite of the continuous threat of VEEV epidemics, no safe and
efﬁcient vaccine, or therapeutic means have been developed for this
encephalitogenic pathogen. A currently available, attenuated strain
VEEV TC-83 is used only as an experimental vaccine for at-risk
laboratory workers and military personnel. It is also employed as a
veterinary vaccine. VEEV TC-83 strain was developed more than four
decades ago by the serial passage of the wild type Trinidad donkey
(TRD) strain of VEEV in guinea pig heart cells (Berge et al., 1961).
During this procedure, TC-83 accumulated 12 genomic mutations
(Kinney et al., 1989), but its attenuated phenotype was shown to rely
only on 2 point mutations (Kinney et al., 1993), which likely had a
positive effect on virus replication in tissue culture and, thus, were the
basis for the selection of the indicated strain. The T120→R mutation,
located in the E2 glycoprotein, increases the protein's positive charge,
and its attenuating effect is achieved by the more efﬁcient binding of
envelope glycoprotein to heparan sulfate (Bernard et al., 2000). This
point mutation has a strong positive effect on virus infectivity in vitro
(Kamrud et al., 2008) and appears to accelerate virus entry into
cultivated cells (Berge et al., 1961; Johnston and Smith, 1988). A
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untranslated region (5′UTR) of the viral genome. This mutation was
shown to have no effect on virus pathogenicity in mice that exhibited
a defect in IFN-α/β signaling (IFN-α/βR−/− mice) (White et al.,
2001), but made the virus less virulent in adult mice, having a fully
competent type I IFN system (Kinney et al., 1993; White et al., 2001).
However, the effect on virulence depended on the mouse strains used
in the studies. VEEV TC-83 also remained highly lethal for the
immunocompetent new born mice after either s.c. or i.c. inoculation
(Ludwig et al., 2001; Paessler et al., 2003). Taken together, these data
and the high frequency of adverse effects in vaccinees (Alevizatos et
al., 1967) suggest to us that the currently available experimental
vaccine does not meet the rigorous requirements for mass human
vaccinations. Thus, the need for new, more efﬁcient and safer VEEV-
speciﬁc vaccine remains a high priority, and additional information
about themolecular basis of VEEV attenuation could be very beneﬁcial
for its rational design. However, till date, the biology of this virus and
its mechanism of replication are poorly understood, further dampen-
ing efforts for vaccine development.
The VEEV genome is represented by a ca. 11.5 kb-long, single-
stranded RNA of positive polarity (Strauss et al., 1984), which mimics
the structure of the cellular mRNAs, in that it contains a 5′ cap and
poly(A)-tail at the 5′ and 3′ ends, respectively. The 5′UTR controls the
translation of a 7500-nt-long, 5′-terminal open reading frame (ORF)
that is translated into viral nonstructural proteins (nsP1–4). These
proteins form the enzyme complex required for the replication of viral
genome and transcription of the subgenomic RNA (Barton et al., 1990;
Lemm and Rice, 1993). The latter RNA encodes the second polyprotein
that is co- and post-translationally processed into the individual
capsid, E2 and E1 proteins that form infectious viral particles (Strauss
and Strauss, 1994). Thus, the 5′UTR-speciﬁc, attenuating G3A muta-
tion in the VEEV TC-83 genome could affect the translation of viral
nonstructural proteins. However, the important feature of the
alphavirus genome's 5′-terminal sequence lies in its involvement in
the processes other than the mere translation of viral nsPs. The
complement of this sequence at the 3′ end of the negative-strand RNA
intermediate functions as a promoter for positive-strand genome
synthesis (Gorchakov et al., 2004b; Niesters and Strauss, 1990a), and
in the case of other alphaviruses, the 5′UTR was also suggested to
function as a part of the promoter of negative-strand RNA synthesis
(Frolov et al., 2001; Gorchakov et al., 2004b). Thus, it is reasonable to
expect that the G3Amutation might modify the promoter activity and
have an effect on the synthesis of virus-speciﬁc RNAs.
In this study, we used a combination of biochemical, biophysical,
and virological approaches to further dissect the effect(s) of the 5′-
terminal, TC-83-speciﬁc mutation on virus replication. Our data
demonstrate that the G3A mutation strongly affects the 5′-terminal
secondary structure of the VEEV genome, but has only a minor effect
on the translation of viral nsPs. However, the indicated mutation
strongly induced replication of the viral genome, downregulated
transcription of the subgenomic RNA, and, thus, affected the ratio of
genomic and subgenomic RNA synthesis. Further, these effects
enhanced virus replication in vitro, and appeared to contribute to its
attenuated phenotype.
Results
Enzymatic analysis of the TRD- and the TC-83-speciﬁc secondary
structures of the 5′UTR
The TC-83-speciﬁc G3A mutation strongly affected the computer-
predicted secondary structure of the 5′ end of the VEEV TRD genome
in terms of the stability and conﬁguration of the very 5′-terminal
stem–loop (Fig. 1A). Both the M-fold (Jaeger et al., 1989) and Vienna
fold (Hofacker, 2003) programs yield identical results for secondary
structure prediction. The TRD-speciﬁc 5′UTRwas predicted to fold intoa hairpin composed of 5 base-pair-long stem and a large (14-nt-long)
terminal loop. In contrast, the predicted secondary structure of the TC-
83 5′UTR contained two short stems separated by an internal, 4-nt-
long bulge, and had a smaller (11-nt-long) loop (Fig. 1A). The
calculated overall free energy of the TC-83-speciﬁc 5′-terminal stem–
loop was expected to be higher than that in the TRD strain, and thus,
its stability at physiological conditions (temperature and salt
concentration) was questionable. Similarly, the mutation had a strong
effect on the computer-predicted folding of the 3′ terminus of the
negative strand of the VEEV genome (Fig. 1B).
To verify the effect of the G3A mutation on the RNA folding, we
performed enzymatic analysis using nucleotide- and dsRNA-speciﬁc
RNases. The 5′-terminal 130-nt-long cDNA fragments of TRD and TC-
83 genomes, comprising the 5′-terminal stem–loop and the ensuing
sequence, whichwas predicted to fold into stable stem–loop SL2, were
synthesized by PCR and cloned into plasmids under control of the
promoter of the T7 DNA-dependent RNA polymerase (see Materials
andmethods for details). The SL2was left to protect the proper folding
of the 5′-terminal sequences. The in vitro-synthesized, 32P-labeled
RNA fragments were partially digested by RNase T1, RNase V1, and
RNase A. The enzymatic probing conditions were optimized to leave at
least 80% of the RNA intact. The cleavage products were then analyzed
on denaturing polyacrylamide gels to reveal the cleavage patterns,
whichwere further used for generating potential secondary structures
and comparing them to those computer-predicted (Fig. 1A).
The data strongly suggested that in TRD 5′UTR the G4 and G5 are
base-paired with C23 and C22 respectively, while in TC-83 they form
base-pairs with C29 and C28. In TC-83, however, both C28 and C29
were cleaved strongly by RNase A in addition to being cleaved by
RNase V1 suggesting that the G4-C29 and G5-C28 base-pairs were not
stable. Nucleotides G7 and G8 are not base-paired in TRD 5′UTR, while
they form the second stem in TC-83 RNA and base-pairs with C23 and
C22, respectively. All of the uridine, cytosine and guanine residues in
both the TRD loop G7-A20 and the TC-83 loop G10-A20 were cleaved
by RNase A or RNase T1, suggesting that they are not involved in base-
pairing and are likely to be in single-stranded form. RNase A and
RNase T1 cleaved C24 and G26 respectively in TC-83 5′UTR,
supporting the possible existence of an internal bulge. In contrast to
TRD 5′UTR, the RNA fragments, predicted to form stems in TC-83-
speciﬁc sequence, were partially cleaved by the single-strand-speciﬁc
nuclease RNase T1 or RNase A, indicating low stability of the RNA
secondary structure under the used experimental conditions. The
overall results of the RNase mapping were consistent with the
predicted secondary structures and supported the hypothesis that the
G3Amutation changed the secondary structure and stability of the 5′-
terminal stem–loop.
In the next experiments, we synthesized 31-nt-long ribo oligo-
nucleotides representing the very 5′-terminal sequences of TRD and
TC-83 genomes (see Materials and methods for details). The thermal
melting temperatures of the TRD and TC-83 5′-terminal stem–loop
RNA fragments monitored by UV-absorbance, revealed that the G3A
mutation decreased the melting temperature of oligonucleotide by
8.2 °C (data not shown). Next, the imino proton signals of the TRD and
TC-83 5′UTR fragments were monitored by NMR spectroscopy, and
the 1D NMR spectra were collected as a function of temperature.
Unlike the UV-monitored melting experiments, the NMR monitoring
provides information on the melting of individual base-pairs. Sharp,
downﬁeld shifted NMR signals in the imino region (11.5–14 ppm)
indicate that the imino protons are base-paired and thus protected
from rapid exchangewith solvent (Fig. 2). At 5 °C, the 1D NMR spectra
of the TRD-speciﬁc 5′-terminal RNA fragment contained 6 signals in
the imino proton region. Most of the signals were assigned to speciﬁc
imino protons using correlations in the 2D NOESY spectra based on
sequential NOE interactions (Wuthrich, 1986). Because no NOE cross-
correlations were observed for some of the imino signals, they were
tentatively assigned as arising from residues G7/G8 or G(s) in the
Fig. 1. The effect of G3Amutation on RNA folding. (A) The computer-predicted (M-fold) secondary structures of the 5′ termini of VEEV TRD and TC-83 genomes, and the results of the
RNase probing. (B) The computer-predicted secondary structures of the 3′ termini of the negative strands of viral genomes.
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G3, G4, G5 and G21 imino protons remained intact, while those of G7
and G8 disappeared. In the case of VEEV TC-83-speciﬁc RNA, the 1D
spectra collected at 5 °C had 5 signals in the imino proton region. As in
the above-described TRD RNA-based experiments, signals were either
speciﬁcally assigned from sequential cross-correlations in 2D NOESY
spectra, or, if no cross-peaks were detected, were provisionally
assigned to the G4 and G5 in the two-base-pair stem and G26 in the
4-nt bulge. The latter assumption was based on the fact that, G4 and
G5 could base-pair with C29 and C28 at low temperatures, and this
further correlated with the results of enzymatic analysis (Fig. 1A).
With an increase in temperature of the TC-83-speciﬁc 31-mer, the
signals corresponding to the G4, G5 and G26 imino protons
disappeared, which was indicative of either very weak hydrogen
bonds or a lack of base-pairing. At 25 °C, TRD-speciﬁc 5′UTR had 4
imino peaks intact, while only 3 imino peaks remained for TC-83-
speciﬁc 5′UTR suggesting that the two 5′UTR RNAs had different
secondary structures. Further, the disappearance of stem-speciﬁc
signals corresponding to G4, G5 and G26 with increase in temperature
suggested that the TC-83-speciﬁc 5′UTR has a less stable secondarystructure compared to that of TRD, whose G3, G4, G5 and G21 imino
signals remained intact at higher temperatures.
G3A mutation has only a minor positive effect on protein translation
The biochemical data demonstrated that the G3A mutation
destabilized the 5′-terminal stem–loop in the VEEV genome and,
thus, could have a strong effect on the translation of the encoded ns
proteins. To test this possibility, we designed reporter, luciferase-
expressing constructs (Fig. 3A) containing either TRD or TC-83-
speciﬁc 5′UTR, and compared the efﬁciency of translation of the
encoded proteins both in vitro and in vivo.
The 5′-terminal, 191-nt-long fragments of the VEEV genome,
encoding either TC-83 or TRD 5′UTRs and 49 aa of nsP1, were cloned
under control of the SP6 promoter. The protein-coding sequence
contained both SL2 and the 51nt-long conserved sequence element
(51-nt CSE) to preserve the secondary structure architecture of the 5′
termini. The nsP1-coding sequence was fused in frame with the ﬁreﬂy
luciferase gene using the ubiquitine gene. This design was aimed at
expressing the luciferase in a free form, because fusion proteins might
Fig. 2. Analysis of stability of the VEEV TRD- and VEEV TC-83-speciﬁc, 5′-terminal stem–loops by NMR. The 31-nt-long RNAmolecules, representing nt 1–31 of the VEEV TRD and TC-
83 genomes, were synthesized in vitro and prepared for NMR as described in Materials and methods. The imino regions of the 1D NOESY spectra presented here were collected at
5 °C, 15 °C, and 25 °C. The signals were assigned from the 2D NOESY spectra, using sequential NOE connectivities.
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strategy of the VEEV genome, the cassettes also contained VEEV-
speciﬁc 3′UTR, followed by the 25-nt-long poly(A) tail.
In the initial experiments, the in vitro-synthesized, capped RNAs
were translated in the rabbit reticulocyte lysate (RRL) in vitro
translation system (see Materials and methods for details). To avoid
saturation of the in vitro translation system with tested RNAs, the
experimentswere performed using different, low concentrations of the
templates. In all of the experiments, the RNAs having the TC-83-speciﬁc
5′UTR, demonstrated a higher efﬁciency of luciferase expression. This
suggested to us that the G3Amutation that destabilizes the 5′-terminal
stem–loop has a detectable positive effect on RNA translation (see the
results of one of the reproducible experiments in Fig. 3B). However, the
effect was moderate and mostly detectable early in the translation
reaction.
To make the data more biologically relevant, we transfected equal
amounts of the same RNAs into BHK-21 cells by electroporation, and
assessed luciferase expression at different times post transfection
(Fig. 3C). The second in vitro-synthesized RNA that encoded the Renilla
luciferase was included in the transfection mixture as a standard for
normalization of the data. However, the electroporation procedure was
found to be very reproducible, and no normalizing was necessary. In all
of the experiments, RNA template encoding the TRD-speciﬁc 5′UTR
produced luciferase almost as efﬁciently as did the template with the
TC-83 5′UTR (Fig. 3C). Considering the possibility that either the 5′UTR
sequence or secondary structure could determine the stability of the
RNAs, we also transfected BHK-21 cells with the same RNAs, labeled in
vitro with 32P. Total cellular RNA was isolated at 0, 1, 2 and 4 h post
transfection, and analyzed by electrophoresis in denaturing conditions,
followed by assessment of the radioactivity in the RNA bands on a
phosphorimager (Fig. 3D). Both RNAs exhibited the same rates of
degradation. Thus, taken together, the results of the in vivo and in vitro
studies suggest that the TC-83-speciﬁc G3Amutation has a verymodest
effect on the translation of the encoded proteins.
Effect of G3A mutation on the synthesis of virus-speciﬁc RNAs
The results of our previous studies and those of other research
groups demonstrated that the 5′ terminus of the alphavirus genome
and its complement in the negative-strand RNA of the replicativeintermediate function as part of the promoters for negative- and
positive-strand RNA synthesis, respectively (Frolov et al., 2001;
Gorchakov et al., 2004b; Niesters and Strauss, 1990a, 1990b). There-
fore, the indicated G3A point mutation could have a signiﬁcant effect
on viral RNA replication. To test this possibility, we designed infectious
cDNA clones for two recombinant alphavirus genomes (Fig. 4A), in
which the subgenomic RNA encoded Sindbis virus-speciﬁc structural
proteins. All of the nonstructural protein genes and cis-acting RNA
elements, including the 5′ and 3′UTRs, 51-nt CSE and the subgenomic
promoter, were derived from the VEEV genome. The genomes of G3/
VEE/SINV and A3/VEE/SINV differed only in the nt3, whichwas either
TRD- or TC-83-speciﬁc (G3 or A3, respectively). The beneﬁt of using
VEEV/SINV chimeras was in their highly attenuated phenotype,
resulting from the lack of VEEV structural protein genes (Petrakova
et al., 2005). The replacement of the VEEV capsid by a SINV-speciﬁc
counterpart was particularly important, because this protein is one of
the determinants of VEEV pathogenesis in vivo and cytopathogenicity
in vitro (Atasheva et al., 2008; Garmashova et al., 2007a, 2007b). Thus,
the experiments with these chimeric viruses did not require high
biocontainment conditions.
Upon transfection into BHK-21 cells of the in vitro-synthesized
RNAs (see Materials and methods for details), the designed chimeras
demonstrated low cytopathogenicity, but the released viruses were
capable of developing plaques in BHK-21 cells under agarose cover in
the presence of low concentrations of serum. The in vitro-synthesized
RNAs exhibited the same infectivity as did VEEV TC-83 RNA in the
infectious center assay (5–10×105 PFU/μg of transfected RNA) and
universal plaque sizes (data not shown), which indicated that no
adaptive mutations were required for the viability of the chimeras.
Virus stocks having titers above 109 PFU/ml were harvested at 24 h
post transfection. Next, we evaluated the synthesis of viral genomic
and subgenomic RNAs at different times post infection by their
metabolic labeling with [3H]uridine in the presence of ActD. The
isolated RNAs were analyzed by agarose gel electrophoresis (Fig. 4B),
and radioactivity in the bands, corresponding to virus-speciﬁc RNAs,
was assessed (Fig. 4C). The results presented in Fig. 4 demonstrated
that the G3A mutation had a positive effect on the replication of viral
genome and, at the same time, affected subgenomic RNA synthesis
(Figs. 4B and C), resulting in an almost 6-fold decrease in the molar
ratio of the subgenomic to genomic (SG:G) RNA synthesis.
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synthesis, we designed VEEV replicons A3/VEErep/Luc/GFP and G3/
VEErep/Luc/GFP, encoding ﬁreﬂy luciferase and GFP under the control
of the subgenomic promoters (Fig. 5A). Both replicons were packaged
into infectious virus particles by using capsid- and glycoprotein-
producing helpers. After determining the titers, cells were infected at
the same multiplicity, and luciferase activity was determined at
different times post infection. In multiple reproducible experiments,
replicons with TC-83-speciﬁc 5′UTR produced lower levels of
luciferase from 6 h post infection, compared to the replicons that
encoded the TRD-speciﬁc 5′UTR. A signiﬁcant, 3-fold difference was
observed by 10 and 12 h post transfection. Similar results were
obtained by measuring GFP ﬂuorescence levels by ﬂow cytometry
(data not shown), as we detected a 3-fold difference in the mean
ﬂuorescence of GFP by 8 h post infection.
A higher level of genomic RNA synthesis by virus harboring G3A
mutation could have multiple explanations. Therefore, to further
understand the effect of the mutation on virus replication, we
designed i) VEEV replicons A3/VEErep/Pac and G3/VEErep/Pac and
ii) defective viral genomes A3/DI/Luc and G3/DI/Luc (Fig. 6A). The
VEEV replicons encoded the viral nonstructural proteins and the Pac
gene, which is unrelated to viral infection, under the subgenomic
promoter; while the DI genomes encoded the 5′-terminal 519
nucleotides of VEEV genome and the ﬁreﬂy luciferase, cloned under
control of the subgenomic promoter (Fig. 6A). The DI RNAs contained
no nonstructural genes, were incapable of self-replication, and, thus,
required trans-complementation with nsPs. Upon delivery into the
same cell, replicon genomes were expected to produce VEEV nsPs for
both their own and DI RNA synthesis. This resulted in a competition
between the DI RNAs and the replicon genomes for the latter proteins.
The efﬁciency of competition was determined by the promoter
sequences, and, ultimately, it deﬁned the level of luciferase expression.
Different combinations of the in vitro-synthesized replicon and DI
genomes were transfected into BHK-21 cells (see Materials and
methods for details), and the luciferase activity was examined at
different times post electroporation. In all of the experiments, the A3/
DI/Luc RNA, having TC-83-derived 5′UTR, produced more luciferase
than did G3/DI/Luc (Figs. 6B and C) and, thus, was more efﬁcient in
utilizing the VEEV replicative enzymes supplied in trans. Notably, the
A3/DI/Luc RNA replication was likely even higher than one might
assume from the data presented in Fig. 6B, as the DI genomes
containing a vaccine strain-speciﬁc G3A mutation were less efﬁcient
in the transcription of the subgenomic RNA (Fig. 4), and still
demonstrated higher levels of luciferase expression.
These results indicated that the more efﬁcient replication of viral
genomes (Fig. 4), having the TC-83-speciﬁc 5′-terminal sequence, was
not the result of the positive effect of G3A mutation on translation
efﬁciency, but rather depended on the modiﬁcation of the RNA
promoter element, leading to its more efﬁcient functioning in genome
replication. The indicated mutation also made the promoter of
positive-strand RNA synthesis more competitive with the subgenomicFig. 3. Analysis of the effect of G3A mutation on the RNA translation efﬁciency. (A) The
schematic representation of the ﬁreﬂy luciferase constructs used to evaluate the effect of
G3A mutation on the template translation. The detailed description of the constructs is
presented inMaterials andmethods. (B) Luciferase activities in theRRL reactionmixtures,
supplementedwith different amounts of in vitro-synthesized G3/Luc and A3/Luc capped
template RNAs. (C) Fireﬂy luciferase expression in BHK-21 cells transfected with the in
vitro-synthesized, capped G3/Luc or A3/Luc RNA. One μg of each template was mixed
with 0.1 μg of Renilla luciferase-encoding RNA, and electroporated into BHK-21 cells, as
described in Materials and methods. Equal aliquots of transfected cells were seeded into
35-mm dishes, and luciferase activities were determined at indicated time points using a
Dual-Luciferase system (Promega). The activity ofRenilla luciferasewas used to normalize
the data. (D) Analysis of the effect of the G3A mutation on RNA stability. Cells were
transfected with similar amounts of 32P-labeled G3/Luc or A3/Luc labeled RNAs. At
indicated time points, total RNAs were isolated and analyzed by agarose gel electro-
phoresis under denaturing conditions. Radioactivity in the RNA bandswas evaluated on a
phosphorimager. The experiments presented in panels B and C were repeated 2 and 3
times, respectively. One of the highly reproducible experiments is presented.
Fig. 5. Expression of heterologous genes encoded by subgenomic RNA of VEEV replicons
having either VEEV TRD- or VEEV TC-83-speciﬁc 5′UTRs. (A) The schematic
representation of the replicons' genomes. (B) BHK-21 cells were infected with packaged
A3/VEErep/Luc/GFP and G3/VEErep/Luc/GFP replicons at an MOI of 10 inf.u/cell and
the expression of luciferase was measured at the indicated time points.
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ratio of SG:G RNA synthesis.
Virus replication
To evaluate the effect of the G3A mutation on virus replication, we
assessed the replication rates of both A3/VEE/SINV and G3/VEE/SINV
variants in BHK-21 and NIH 3T3 cells. As indicated above, both viruses
were poorly cytopathic, but demonstrated efﬁcient replication in both
cell types, albeit at lower rates than did VEEV TC-83 (Fig. 7). The more
efﬁcient replication of TC-83 was not surprising, because formation of
infectious viral particles was determined by the interaction of the
genomewith heterologous, SINV-derived capsid protein. Our previous
studies strongly indicated that the VEEV ns polyprotein-coding
sequence contains RNA elements, so-called packaging signals (PS),
that promote genome packaging into the nucleocapsid (Volkova et al.,
2006). Therefore, it is highly unlikely that the SINV capsid is capable of
recognizing the VEEV-speciﬁc PS, and, based on very low levels of the
nucleotide sequence identity, it was impossible to expect presence of
SINV-speciﬁc PS in the VEEV-speciﬁc sequence. Efﬁcient formation of
viral particles was rather determined either by close compartmenta-
lization of the capsid and newly synthesized RNA or by the
presentation of the latter RNA by the replicative complexes for
packaging. In multiple repeat experiments, the replication of A3/VEE/
SINV was always detectably higher than that of G3/VEE/SINV. This
increase correlated with the more efﬁcient synthesis of viral genome
RNA, suggesting its critical role in virus production.Fig. 4. Synthesis of virus-speciﬁc RNAs in the cells infected with A3/VEE/SINV and G3/
VEE/SINV. (A) The schematic representation of chimeric virus genomes. Open boxes
indicate VEEV-speciﬁc sequences and ﬁlled boxes indicate SINV-speciﬁc structural
genes. (B) BHK-21 cells were infected with G3/VEE/SINV and A3/VEE/SINV at an MOI
of 10 PFU/cell. RNAs were labeled with [3H]uridine in the presence of ActD for 4 h from
2, 4 and 6 h post infection, then isolated and analyzed by agarose gel electrophoresis
under denaturing conditions as described in Materials and methods. Bands corre-
sponding to genomic and subgenomic RNAs were visualized by autoradiography. G and
SG indicate positions of the viral genomic and subgenomic RNAs, respectively. (C) RNA
bands were excised, and radioactivity in the genome and subgenomic RNA was
measured by liquid scintillation counting. One of three reproducible experiments is
presented.
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In the infected cells, alphaviruses produce only a handful of
proteins, which function in replication of the viral genome and
assembly of infectious virions. In addition to their role in virus
replication and assembly, these proteins also determine other aspects
of virus-host cell interactions, such as the development of a cytopathic
effect and downregulation of the cell response to virus replication
(Fazakerley et al., 2002; Frolova et al., 2002; Gorchakov et al., 2004a,
2005, 2008a). The level of RNA replication required for efﬁcient
packaging and assembly of virions depends on the functioning of the
promoter elements that are encoded by the virus genome and
negative-strand RNA intermediate (Strauss and Strauss, 1994). The
very 5′ end of the VEEV genome has been shown to contain two
functional elements (Gorchakov et al., 2004b; Michel et al., 2007), one
of which is located in the 5′UTR, and the second is present in the nsP1-Fig. 6. Replication of the DI RNAs, encoding VEEV TRD- and VEEV TC-83-speciﬁc 5′UTRs,
in the presence of VEEV replicons. (A) The schematic representation of the DI RNA and
VEEV replicon genomes used in the study. (B and C) BHK-21 cells were co-transfected
with 2 μg of indicated replicons and 2 μg of indicated DI RNAs. Equal numbers of
electroporated cells were seeded into 35-mm dishes and incubated at 37 °C in 5% CO2.
At the indicated time points, cells were lysed, and luciferase activity was measured as
described in Materials and methods.
Fig. 7. Analysis of virus replication in BHK-21 and NIH-3T3 cells. Cells were infected
with G3/VEE/SINV and A3/VEE/SINV at an MOI of 10 PFU/cell. Media was replaced at
the indicated time points, and virus titers were analyzed by plaque assay on BHK-21
cells. The experiments were repeated three times with very high reproducibility. Figure
represents one of the repeated experiments.coding sequence. The latter cis-acting element, the 51-nt CSE, is a
replication enhancer that appears to function in VEEV RNA replication
by positioning of the replicative enzymes in the initiation of the RNA
synthesis (Michel et al., 2007). The negative effect of the mutations in
the VEEV and SINV genome 51-nt CSEs can be compensated by the
mutations in nsP2 and nsP3 (Fayzulin and Frolov, 2004; Michel et al.,
2007). The 5′UTR (more precisely, its complement in the negative
strand of the viral genome) was deﬁned as a core promoter, and some
of the mutations in this sequence or its replacement by the 5′UTR
derived from other alphaviruses, have deleterious effects on RNA
replication (Gorchakov et al., 2004b; Niesters and Strauss, 1990a). Our
previously published data and those of other research groups
demonstrated that the G3A mutation in the VEEV 5′UTR strongly
affects the pathogenicity (Kinney et al., 1993;White et al., 2001) of the
virus and the ability of the VEEV-speciﬁc replicons to cause CPE
(Petrakova et al., 2005). Interestingly, there was no correlation
between these two characteristics: the replication of the VEEV TC-
83-speciﬁc replicon, which lacks the structural genes (A3/VEErep/
Pac), is more cytopathic (Petrakova et al., 2005). Cells, transfected
with A3/VEErep/Pac replicons form fewer PurR foci and demonstrate
dramatically slower growth rates compared to those transfected with
the replicons having the same nucleotide sequence but G3 in the 5′
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makes the virus less pathogenic in mice (Kinney et al., 1993; White
et al., 2001), albeit this effect appears to be mouse strain- and age-
dependent.
Our new data provide a plausible explanation for the variances in
the cytopathogenicity of the replicons differing only in the nt3 of the
5′UTR and suggest that the secondary structure of this RNA fragment
plays crucial role(s) in virus replication. The TC-83-speciﬁc G3A
mutation changed folding of the 5′UTR and, based on computer
predictions, the secondary structure of the 3′ end of the negative
strand of VEEV genome as well. Its effect on the RNA secondary
structure was further conﬁrmed by enzymatic probing, UV-melting
experiments and NMR studies. Our results clearly demonstrate that
the indicated mutation reduced the stability of the very 5′-terminal
stem–loop and, most likely, caused a similar change in the 3′ end of
the negative-strand intermediate. Accordingly, this mutation could
affect multiple processes of virus replication. The effect of this
mutation on the secondary structure of the negative strand is not
very clear. This uncertainty comes from the fact that, to date, it has not
been unambiguously demonstrated whether the 3′ terminus of the
negative strand is annealed to the complementary sequence at the 5′
UTR of viral genome, or if it remains in free form and is capable of
folding into the stem–loop during virus replication. The experimental
data from our previous studies indicate that the replicative RNA
intermediate is a dsRNA (Gorchakov et al., 2008b); however, the
negative-strand RNA could function in both genomic and subgenomic
RNA synthesis in vitro (Li and Stollar, 2004, 2007), which suggests that
dsRNA formation, at least in the promoter sites, is not necessary. In
addition to these ﬁndings, the in vitro experiments have shown that
the 3′ end of the negative-strand genome can bind a number of
cellular proteins (Pardigon et al., 1993). Moreover, the genomic RNA
synthesis is partially terminated in close proximity to another (SG)
promoter (Wielgosz and Huang, 1997), and, in the replicative
intermediate, this sequence is also sensitive to the RNase digestion
(Simmons and Strauss,1972). The latter phenomena lead us to suggest
that in the dsRNA intermediate, the RNA promoter elements might be
present in the ss form. Based on these data, we hypothesized that the
G3A mutation-speciﬁc change in the RNA secondary structure and
stability could result both in modiﬁcation of the translation efﬁciency
of the RNA and affect the function of the 5′UTR-associated promoter(s)
in the RNA synthesis.
It was surprising to ﬁnd that the G3A mutation had almost no
effect on the 5′UTR activity in translation of the encoded proteins,
because stable stem–loops at the 5′ terminus are generally believed to
strongly affect the translation efﬁciency of the templates (Kozak,
2005). However, some of the available data suggest that this is also the
case for another alphavirus, Sindbis virus. The pathogenicity of the
neuroinvasive strain of SINV was shown to be determined by the
mutation of nt8 in the 5′UTR (Dubuisson et al., 1997). This mutation
stabilized the 5′-terminal stem, but did not alter the translation
efﬁciency of the RNA in vitro. The pathogenic and nonpathogenic
strains of SINV also differ in nt5. As in the case of VEEV G3A mutation,
the G5A mutation, which is present in tissue culture-adapted strain of
SINV and in the widely used SINV Toto1101, is also predicted to
destabilize the 5′-terminal stem (McKnight et al., 1996), but it caused
only aminor increase in the efﬁciency of RNA translation (Nickens and
Hardy, 2008).
The G3A mutation in the VEEV genome mediated a higher level of
RNA replication and downregulated transcription of the subgenomic
RNA. Analysis of the level of viral RNA synthesis in the infected cells
and the DI RNA competition experiments strongly suggested that the
promoters of the positive-strand genome synthesis and the transcrip-
tion of the subgenomic RNA appear to compete for the replicative
enzymes. In the case of the TC-83-speciﬁc 5′UTR, the balance is shifted
towards genomic RNA synthesis. Based on the available data on SINV
replication (Gorchakov et al., 2004b; Nickens and Hardy, 2008), it ispossible that the G3A mutation might also affect the negative-strand
RNA synthesis due to the interaction of the 3′ and 5′ ends of the viral
genome. Nevertheless, this additional effect, on the other hand, would
not affect the current hypothesis that the nt3 mutation in VEEV TC-83
changes RNA and virus replication by favoring viral genomic RNA
synthesis.
The ability of VEEV to cause a disease was previously shown to
depend onmultiple factors and, ﬁrst of all, on the amino acid sequence
of E2 glycoprotein. A single amino acid change in this protein led to
profound attenuation of the virus (Kinney et al., 1993). Secondly, the
VEEV capsid protein was found to interfere with nuclear-cytoplasmic
trafﬁcking and, ultimately, to inhibit the transcription of cellular
messenger and ribosomal RNAs. Modiﬁcations of the deﬁned 35-aa-
long capsid-speciﬁc peptide or its replacement, with one derived from
the SINV capsid, made the virus dramatically less cytopathic and
strongly attenuated (Garmashova et al., 2007a). In this study, we have
demonstrated that the TC-83-speciﬁc, 5′UTRmutation strongly affects
the secondary structure of the 5′ terminus of the viral genome. The
G3A mutation has no signiﬁcant effect on the RNA translation
efﬁciency, but increases replication of both viral genome and virus
itself in tissue culture. Similar G5A mutationwas previously described
for the cell culture-adapted SINV strain. Thus, higher RNA replication
rates of both VEEV and SINV might affect the intimate balance
between the virus-induced cell response and the ability of the virus to
interfere or escape its development (Nickens and Hardy, 2008; White
et al., 2001). This, in combination with the previously described, G3A-
induced higher sensitivity to IFN-α/β (White et al., 2001), appears to
form a strong basis for the attenuated phenotype of VEEV TC-83.
Materials and methods
Cell cultures
BHK-21 cells were kindly provided by Dr. Sondra Schlesinger
(Washington University, St Louis, MO). NIH 3T3 cells were obtained
from the American Type Tissue Culture Collection (Manassas, Va).
BHK-21 and NIH 3T3 cells were propagated in Alpha MEM supple-
mented with 10% fetal bovine serum (FBS) and vitamins.
Plasmid constructs
The parental plasmid with VEEV TC-83 genome was described
elsewhere (Petrakova et al., 2005). It contained a cDNA of the viral
genome under the control of an SP6 DNA-dependent RNA polymerase
promoter. pG3/VEE/SINV, encoding the genome of G3/VEE/SINV
chimeric virus genome was described elsewhere as VEE/SINV
(Garmashova et al., 2007b; Petrakova et al., 2005). In this report,
the name of the virus was changed to make it consistent with other
constructs. This plasmid encoded 5′UTRof the VEEV TRD strain, 3′UTR,
subgenomic promoter and ns polyprotein-coding sequence fromVEEV
TC-83 and structural polyprotein-coding sequence from SINV
Toto1101 (Rice et al., 1987). pA3/VEE/SINV differed only by one
nucleotide (A3), speciﬁc for the VEEV TC-83 5′UTR. In both genomes,
the poly(A) sequence was followed by a MluI restriction site. pA3/
VEErep/Pac and pG3/VEErep/Pac replicons had viral structural genes
replaced by a puromycin acetyltransferase (Pac) sequence, and were
described elsewhere (Petrakova et al., 2005).
All other plasmids encodingmodiﬁedVEEV genomes and luciferase
were constructed by standard PCR-based mutagenesis and cloning
methods. After cloning into the plasmids, all of the PCR fragmentswere
sequenced to exclude the possibility of spontaneous mutations. The
details of the cloning procedures and sequences can be provided upon
request. pG3/Luc and pA3/Luc encoded the promoter for the SP6DNA-
dependent RNA polymerase, followed by nt 1–191 of the viral genome,
fused with the entire ubiquitin gene and ﬁreﬂy luciferase-coding
sequence. This protein-coding sequence was followed by VEEV TC-83-
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linearization of the plasmid before in vitro transcription reaction.
pG3/DI/Luc and pA3/DI/Luc plasmids encoded defective viral
genomes under control of the SP6 promoter. These genomes
contained the 5′ terminal 519 nt derived from VEEV TRD or VEEV
TC-83 genomes, respectively, followed by nt 7291–7564 (encoding
VEEV subgenomic promoter), a ﬁreﬂy luciferase gene, 3′ terminal nt
11,202–11,446 of VEEV genome, poly(A) tail and MluI restriction site.
RNA transcriptions
All of the plasmidswere puriﬁed by centrifugation in CsCl gradients.
Prior to transcription, they were lineraized by MluI, and RNAs were
synthesized in vitro by SP6 RNA polymerase in the presence of cap
analog (Rice et al., 1987) under the conditions recommended by the
manufacturer (Invitrogen). The yield and integrity of the transcripts
were monitored by gel electrophoresis under nondenaturing condi-
tions, followed by analysis of the RNA concentration on a FluorChem
imager (Alpha Innotech). For virus rescue and analysis of DI RNA
replication, the appropriate volumes of reactionmixtures were directly
used for electroporation. For comparative studies of translation
efﬁciencies of the Luc-coding RNAs, the transcripts were additionally
puriﬁed using RNeasy columns (Qiagen), and RNA concentration was
measured as described above.
RNA transfections
BHK-21 cells were electroporated with 2 μg of in vitro-synthesized,
viral genome RNA using previously described conditions (Liljeström
et al., 1991), and cells were seeded into 100-mm dishes. The released
viruses were harvested 24 h post transfection. Titers were determined
by a plaque assay on BHK-21 cells. For analysis of DI RNA replication,
replicons and DI RNAs were co-electroporated as described in the
ﬁgure legends. Equal amounts of cells were seeded into 35-mmdishes,
and luciferase activity was measured at different times post trans-
fection by using a luciferase assay kit according to the manufacturer's
instructions (Promega). To assess the translation efﬁciency of the
templates, equal amounts of A3/Luc and G3/Luc RNAs were electro-
porated into BHK-21 cells, equal aliquots of the cells were seeded into
35-mm dishes, and luciferase activity was measured at different times
post transfection. To determine the stability of the RNAs, similar
amounts of 32P-labeled, in vitro-synthesized A3/Luc and G3/Luc RNAs
were electroporated into BHK-21 cells, equal aliquots of the cells were
seeded into 35-mm dishes. At the indicated times, RNAs were isolated
by using TRizol reagent as recommended by the manufacturer
(Invitrogen), followed by electrophoresis in agarose gel and auto-
radiography. Dried gels were further analyzed on a Storm phos-
phorimager (Molecular Dynamics). The radioactivity detected in the
RNA bands, was normalized on that found in the 0 h samples isolated
immediately after RNA transfection. Replicons were packaged into
infectious viral particles by co-electroporation of the in vitro-
synthesized replicon and two helper RNAs (Volkova et al., 2006)
into BHK-21 cells. Media were harvested 24 h post electroporation,
and titers of the packaged replicons were determined by infecting
BHK-21 cells with different dilutions of the samples and measuring
the numbers of infected, GFP-expressing cells after 8 h of incubation at
37 °C in a CO2 incubator.
In vivo translation assay
Different amounts of in vitro-synthesized A3/Luc and G3/Luc
RNAs, presented in Fig. 3, were translated in 10 μl of the rabbit
reticulocyte lysate (RRL) system according to the manufacturer's
instructions (Promega). Aliquots of the reaction mixtures were taken
after 1 h incubation at 30 °C, and luciferase activity was measured by a
luciferase assay kit according to themanufacture's protocol (Promega).Analysis of virus replication
5×105 BHK-21 or NIH 3T3 cells were seeded into 35-mm dishes.
After 4 h of incubation at 37 °C in 5% CO2, monolayers were infected at
the multiplicities of infection (MOI) indicated in the legend to Fig. 7,
for 1 h, washed three times with phosphate-buffered saline (PBS), and
overlaid with 1 ml of complete medium. At the indicated times post
infection, media were replaced by fresh media, and virus titers in the
harvested samples were determined by plaque assay on BHK-21 cells
as previously described (Lemm et al., 1990).
RNA analysis
BHK-21 cells were infected with chimeric viruses at an MOI of
10 PFU/cell. At the indicated times post infection, the intracellular
RNAs were labeled with [3H]uridine (20 μCi/ml), in the presence of
1 μg/ml of dactinomycin (ActD)/ml for 4 h at 37 °C in 5% CO2. RNAs
were isolated from the cells using TRIzol reagent according to the
manufacturer's instructions (Invitrogen). The RNAs were denatured
with glyoxal in dimethyl sulfoxide and analyzed by agarose gel
electrophoresis as previously described (Bredenbeek et al., 1993). For
quantitative analysis, the RNA bands were excised from the 2,5-
diphenyloxazole (PPO)-impregnated gels, and the radioactivity was
measured by liquid scintillation counting.
Enzymatic analysis of the RNA secondary structure
RNA secondary structure mapping experiments were carried out
using a protocol and reagents obtained from Ambion. Brieﬂy, the in
vitro-synthesized RNA fragments were puriﬁed by gel electrophoresis,
eluted, dephosphorylated and 5′ labeled using T4 polynucleotide
kinase from theKinaseMax kit (Ambion) and [γ-32P] ATP (Amersham).
Labeled RNAswere puriﬁed by denaturing 12% polyacrylamide gel, and
eluted into SDS-containing buffer, followed byethanol precipitation. In
some experiments, 32P-labeled RNA transcripts were digested in the
buffer containing 10 mM Tris–HCl pH 7.0, 100 mM KCl, 10 mMMgCl2),
supplemented with 1 μg of yeast tRNA. Digestions were performed by
either RNase T1 (0.01 or 0.001 U/μl), or RNase A (0.01 or 0.001 μg/ml),
or RNase V1 (0.001 or 0.0001 U/μl) at 25 °C for 10 min. Samples were
precipitated, re-suspended in 10 μl of denaturing loading buffer, and
subjected to electrophoresis in 12% or 20% sequencing gels. Alkaline
hydrolysis ladders were obtained by treatment of 5′ end-labeled
transcripts in the alkaline buffer (Ambion) at 95 °C for 5 min.
NMR spectroscopy
The 31-merRNAmolecules, corresponding to residues 1–31of the5′
UTRs of VEEV TRD and VEEV TC-83 genomes (see Fig. 1A for details),
were synthesized by in vitro transcription of the DNA template using
the T7 DNA-dependent RNA polymerase. The HPLC-puriﬁed DNA
templates were obtained from IDT and additionally tested by electro-
phoresis in a polyacrylamide gel. After transcription, RNA molecules
were precipitated by ethanol and puriﬁed on 20% polyacrylamide gels
supplementedwith 8M urea. The RNAs were extracted from the gel by
electroelution, recovered by ethanol precipitation and concentrated by
centrifugation using a Centricon-3 concentrator (Millipore). The
samples were dialyzed against 10 mM Na-phosphate buffer (pH 6.5),
supplementedwith10mMKCl and0.05mMEDTA, and lyophilized. The
quality of the samples was conﬁrmed by gel electrophoresis. For the
experiments involving exchangeable hydrogen or non-exchangeable
hydrogen, the lyophilized RNA sampleswere then dissolved in 300 μl of
either 90% H2O/10% D2O or 99.96% D2O, respectively. In order to
facilitate stem–loop formation the RNA samples were heated to 95 °C
for threeminutes followedby rapid coolingon ice to reduceduplexRNA
formation. RNA concentrations in the samples used for the NMR
experiments were 0.25 mM.
220 R. Kulasegaran-Shylini et al. / Virology 387 (2009) 211–221All of the NMR spectra were acquired on Varian Direct Drive type
spectrometers (Varian Associates, Palo Alto, CA), operating at either
750 MHz or 800 MHz, equipped with pulsed ﬁeld gradients and
direct-drive architecture. Melting of the RNA molecule was studied by
monitoring the imino proton signals as a function of temperature. 1D
NOESY spectra were collected at 5 °C, 10 °C, 15 °C, 20 °C, and 25 °C
using spectral widths of 16,000 Hz and 1024 complex data points. To
identify base-pairing patterns and NOE interactions between
exchangeable hydrogens, 2D NOESY spectra (with 250 ms and
400 ms mixing times) were acquired at 5 °C and 25 °C, spectral
widths of 7600 Hz and 8000 Hz and 2048 complex data points, using
samples dissolved in 90%H2O/10% D2O. Additional NOESY spectra,
using identical NMR parameters, were acquired with the samples in
99.96% D2O. Acquired NMR data were processed by using VNMRJ
software. HOD signal at 4.76 ppmwas used for referencing the 1D and
2D spectra.
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